Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002368753 | SCV002660961 | uncertain significance | Cardiovascular phenotype | 2019-04-01 | criteria provided, single submitter | clinical testing | The p.I20997F variant (also known as c.62989A>T), located in coding exon 162 of the TTN gene, results from an A to T substitution at nucleotide position 62989. The isoleucine at codon 20997 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003138214 | SCV003825914 | uncertain significance | not provided | 2019-06-21 | criteria provided, single submitter | clinical testing |